Periodontal DiseasesNCT05372835
Hypochlorous Acid Mouthwash, Oral Bacteria, and Staphylococcus Aureus
A study testing La Chlogen mouthwash, water and La Chlogen mouthwash and La Chlogen periodontal flosser in people with Periodontal Diseases, run by Kaohsiung Medical University at 1 site in Taiwan.
Trial summary
Mouthwash is one method of maintain oral health and to reduce the dental plaque and gum inflammation. However, the effects of mouthwash on oral bacteria were not consistent among different brands of them. Read more about this study
- Who is it for?
- Ages 35 to 70 yearsHealthy volunteers can take part
- Conditions the study is for
- Periodontal Diseases
- What is being tested?
- La Chlogen mouthwash, water and La Chlogen mouthwash and La Chlogen periodontal flosser
- Could I receive a placebo?
- Yes, some participants may receive a placebo
- How many people
- 83 participants
- Where
- 1 siteTaiwan
- Study dates
- 20 Mar 2020to 22 Feb 2022
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 35 to 70 years
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- All the participants were between 35 and 70 years old.
- Clinical diagnosis of periodontal disease
- Must be able to rinse liquid (mouthwash or water) in mouth and split out saliva into a collection tube
Who cannot join
- diagnosed mental illness
- incapacitated patients
- antibiotics or immunosuppressive drugs taken for the two consecutive weeks preceding study commencement
- pregnant
- smokers
- cancers
- Insulin dependent diabetes
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Effects of Hypochlorous Acid Mouthwash on Oral Bacteria in Patients With Periodontal Disease and Staphylococcus Aureus
Mouthwash is one method of maintain oral health and to reduce the dental plaque and gum inflammation. However, the effects of mouthwash on oral bacteria were not consistent among different brands of them. The aims of present study were to determine the effects of a new designed mouthwash with hypochlorous acid on oral bacteria and Staphylococcus aureus. All participants were invited as a volunteer to attend this study from a private dental clinic and diagnosed by the same dentist. Patients with periodontal diseases were randomized selected as mouthwash group and mouthwash plus dental flossing device (La Chlogen, Taiwan) group. Patients for regular dental visit and without periodontal disease were invited as a control group having mouth rinse with water. After the inform consent was signed, participants completed the intervention study, saliva collection, and a simple survey under the guide of a dental assistant. Saliva samples were collected before and after the intervention for bacterial DNA extraction. A real-time polymerase chain reaction and S. aureus with serial dilutions were applied for the estimation of total oral bacterial count (TOBC) in saliva. An in vitro assay with CCK-8 reagent was apply to test the antibacterial ability of mouthwash.
Read the detailed description
Finally there were 83 person recruited into the present study. A total of 53 patients with periodontal disease diagnosed by a periodontist, who were randomly assigned to the mouthwash-only group (26 patients) or the mouthwash plus periodontal flosser group (27 patients). There were 30 controls recruited into the present study. For the determination of oral bacterial counts, a real-time polymerase chain reaction and a pure strain of Staphylococcus aureus with a serial dilutions were applied to create a standardized growth curve for the estimation of oral bacterial counts in saliva. Before the intervention, participants were asked to rinse 5 ml of water to deplete the food debris and the other residues in mouth. The intervention was asked participants to rinse the 15 ml mouthwash or water for 5 minutes in oral cavity.
Participants were asked their health history and use of dental cleaning tools. The participants underwent relevant oral health examinations, and their oral health indices were also recorded. The mouthwash used for intervention in the present study was the 15 mL of commercially available La Chlogen mouthwash (Republic of China Patent No. M616466) for 5 minites. The main ingredient in the mouthwash is low-concentration high-purity HOCl (100 ppm). The HOCl solutions can be also used in conjunction with the La Chlogen periodontal flosser (Republic of China Patent No. M590033). The controls were instructed to gargle with pure water (15 ml) for 5 minutes. Each participant first underwent a pretest, in which after the participants' saliva samples were collected, their total oral bacterial count (TOBC) were measured. Thereafter, each participant rinsed their mouth with their assigned liquid (mouthwash, mouthwash plus periodontal flosser or water) without spitting. After 5 minutes, the participants spit out the liquid, and these saliva samples were collected and tested to determine the TOBC.
Each participant underwent two saliva sample collection sessions: pretest and posttest. Before the saliva collection, participant rinsed with 5 ml of water. After this, participants were asked to expectorate over a maximum period of 3 minutes into a 50 ml sterile centrifugation tube (Creative Biotechnology Co., Ltd., Taiwan) for the collection of unstimulated whole saliva. The collected specimen was then immediately placed in a portable ice box for storage, returned to the laboratory for the same-day bacterial DNA extraction. The saliva volume and weight of each sample was also recorded before the bacterial genomic DNA extraction process.
TOBC analysis: After the extraction of the bacterial genomic DNA, The real-time polymerase chain reaction (RT-PCR) techniques were used to quantify the total counts of oral bacteria in the saliva samples. Saliva sample was centrifuged at 2500 rpm for 5 minutes. The pellet was suspended with 300µl lysozyme solution (2.5 mg/mL). After being mixed evenly, the mixture was transferred into a 1.5mL eppendorf tube and placed on ice for 1 hour. Thereafter, 10% SDS (20µL), 0.5M EDTA (80µL), and 20mg/mL proteinase K (10µL) were added to each tube in sequence; the contents of each tube were mixed evenly and placed in a 55°C oven for overnight. Next, 10M NH4OAC was added to the mixture in equal volume. The mixture was placed on ice for 5 minutes and centrifuged at 13,000 rpm for 10 minutes. The resulting supernatant was placed into a 1.5-mL centrifuge tube. Isopropanol was added to the resulting mixture in equal volume, and the mixture was stored at -20°C for overnight or -80°C for 1 hour. After centrifugation for 10 minutes at 13,000 rpm, the supernatants were removed from the precipitates, 75% alcohol (500µL) was added and left to stand for 5 minutes, and the mixture was centrifuged for 10 minutes at 13,000 rpm. The alcohol was then removed. Next, 100% alcohol (500µL) was added to the pellet. The mixture was left to stand for 5 minutes and subsequently centrifuged for 10 minutes at 13,000 rpm. Finally, the alcohol in the tube was poured out, and the centrifuge tube was placed upside down to allow any remaining alcohol to evaporate. Finally, the DNA precipitates were dissolved using an appropriate amount of sterilized water, placed into an oven at 55°C for 5 minutes, and stored at -20°C. Generally, the DNA specimens with an OD260/ OD280 ratio of 1.4 or higher. The concentration of recovered DNA was calculated on the basis of a concentration of 50 µg/mL at OD260 = 1.00, which was determined to be suitable for estimating the TOBC of each sample after the DNA quantification. Staphylococcus aureus (ATCC 29213) was used as the reference strain in bacterial growth curve estimation. After overnight culturing, the bacterial solution was serially diluted five times to generate specimens with different concentrations of S. aureus. A total of 10 µL of each of the specimens were taken and spread on the agar medium to attain concentrations of 2.5 × 103 to 3.9 × 107 CFU/mL. A volume of 1 mL of each different bacterial concentration was taken for bacterial DNA extraction. The extracted bacterial genomic DNA was stored frozen at -80°C until the RT-PCR test was conducted. Before the RT-PCR test, the bacterial genomic DNA concentration was measured. RT-PCR tests mainly detect 16S rRNA, and a StepOnePlus system (Applied Biosystems, Foster City, CA, USA) was used to establish a standard curve of S. aureus concentration. The sequence of the forward primer and reverse primer used were 5'-CCT ACG GGA GGC AGC AG-3' and 5'-CCG TCA ATT CMT TTR AGTT T-3', respectively.16 The coverage rates of selected forward and reverse primer pair for common bacterial species are 94.9% and 92.8%, respectively.16 The total PCR volume was 25 uL, comprising 5.5 µL of ddH2O, 1.0 µL of 5-µM preprimer, 1.0 µL of 5-µM reverse primer, 12.5 µL of SYBR solution, and 5.0 µL (0.25 µg) of DNA. The RT-PCR reaction conditions were as follows: 94°C for 10 minutes; followed by 35 cycles of 95°C for 45 seconds, 58°C for 40 seconds, and 72°C for 60 seconds; and followed by one cycle of 72°C for 7 minutes. A regression equation derived from the standard curve and the RT-PCR results were used to calculate the bacterial concentration in each saliva sample. The RT-PCR assay was conducted two duplicates for each sample, and the coefficient of variation of the threshold was varied between 2% and 12%. Human blood DNA was used as a negative control group.
Antibacterial activity of the mouthwash solution: The pure-cultured S. aureus used as the standard strain was plated on a culture plate (10 cm in diameter) containing 1.5% (g/L) luria broth agar and cultured overnight. A single colony was selected and placed in a conical flask containing LB nutrient liquid, shaken, and recultured overnight, and the resulting solution was serially diluted and coated on the plate to calculate the number of bacteria per unit volume. Finally, a Cell Counting Kit 8 (CCK-8, Engreen Biosystem) commercial reagent was used to evaluate the antibacterial effect of the mouthwash. Each experiment was performed in duplicate. Solutions containing different colony forming units (0, 10, 100, 1000, 10000, 100000, and 1000000) of S. aureus were centrifuged at 2000 rpm for 5 minutes to concentrate the bacteria; after the liquid was removed, 180 µL of fresh culture medium was added to suspend the bacteria in the culture medium. The bacteria solution was transferred to a 96-well plate. To evaluate the antibacterial effect of the mouthwash, 20 µL of the mouthwash was added to the mixture of the bacterial solution. The mixture was incubated at 37°C for 2 hours. Finally, 10 µL of CCK-8 reagent was added and mixed well. The resulting mixture was incubated at 37°C for 2 hours, and the absorbance at 450 nm was measured using an ELISA reader. The standard growth curve could be established for the estimation of the number of bacteria in the mixture and their survival rate of the bacteria, which were then compared with the standard curve.
Statistical analysis: After the data collection and checking were complete, the finalized debugged files were transferred to a computer with statistical software for statistical analysis. The descriptive statistics used included frequency distribution tables, percentages, means, and standard deviations. In the TOBC analysis, in addition to descriptive statistics, a t test, chi-square test, and linear regression analysis were conducted to assess and compare the changes in the bacterial counts of the participants' saliva after the intervention period. Considering the small sample size and the distribution of TOBC, nonparametric statistical methods were used for analysis. The Wilcoxon rank-sum test was used to identify differences in the numerical data of the intervention group and the control group, the Wilcoxon signed-rank test was used to identify changes in numerical data between the baseline and post-intervention, and the Kruskal-Wallis test and a post hoc Tukey test were used to identify differences in numerical data of three or more groups.
- Conditions
- Periodontal Diseases
- Being tested
- La Chlogen mouthwash, water, La Chlogen mouthwash and La Chlogen periodontal flosser
- Medical subject headings
- Periodontal Diseases
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
La Chlogen mouthwashOther
Patients with periodontal disease were randomized into mouthwash group. Before the intervention, participants were asked to rinse 5 ml of water to deplete the food debris and the other residues. After this, the intervention was asked participants to rinse the commercially available La Chlogen mouthwash in mouth without spitting. After 5 minutes, the participants spit out the liquid, and the saliva samples were collected for further analysis.
waterOther
Patients without periodontal disease were selected as a control group. Before the intervention, participants were asked to rinse 5 ml of water to deplete the food debris and the other residues. After this, the intervention was asked participants to rinse the pure water in mouth without spitting. After 5 minutes, the participants spit out the liquid, and the saliva samples were collected for further analysis.
La Chlogen mouthwash and La Chlogen periodontal flosserOther
Patients with periodontal disease were randomized into mouthwash and periodontal flosser group. Before the intervention, participants were asked to rinse 5 ml of water to deplete the food debris and the other residues. After this, the La Chlogen mouthwash in conjunction with the La Chlogen periodontal flosser were applied in mouth without spitting for interventions. After 5 minutes, the participants spit out the liquid, and the saliva samples were collected for further analysis.
| Study group | Role | What they receive |
|---|---|---|
| mouthwash | Experimental | The 15 mL of commercially available La Chlogen mouthwash (Republic of China Patent No. M616466) was used for intervention to rinse in mouth for 5 minutes. The main ingredient in the mouthwash is low-concentration high-purity HOCl (100 ppm) solution. Receives: Other: La Chlogen mouthwash |
| mouthwash and periodontal flosser | Experimental | The 15 ml of commercially available La Chlogen mouthwash (Republic of China Patent No. M616466) in conjunction with the La Chlogen periodontal flosser (Republic of China Patent No. M590033) were used for intervention in the mouth for 5 minutes. The main ingredient in the mouthwash is low-concentration high-purity HOCl (100 ppm) solution. Receives: Other: La Chlogen mouthwash and La Chlogen periodontal flosser |
| control | Placebo comparator | The pure water without HOCl chemical was applied in this intervention to rinse in mouth for 5 minutes. Receives: Other: water |
What is being measured
The primary outcome is the main question the study is designed to answer.
Total oral bacterial count before the intervention
Before the intervention, saliva samples were collected for oral bacterial DNA extraction.The saliva volume and weight of each sample was also recorded before the bacterial genomic DNA extraction process. A real-time polymerase chain reaction and S. aureus with serial dilutions were applied for the estimation of total oral bacterial count (TOBC) in saliva. The differences in TOBC among the mouthwash group (MW), mouthwash and periodontal flosser group (MWF), and control group were determined using statistical analysis.
Measured: Before the intervention starting
Total oral bacterial count after the intervention
After the intervention, saliva samples were collected for oral bacterial DNA extraction. The saliva volume and weight of each sample was also recorded before the bacterial genomic DNA extraction process. A real-time polymerase chain reaction and S. aureus with serial dilutions were applied for the estimation of total oral bacterial count (TOBC) in saliva. The difference in TOBC between before and after intervention was determined using statistical analysis
Measured: Immediately after the intervention
Survival rate of S. aureus after the incubation with 10% (v/v) mouthwash
An in vitro assay and CCK-8 reagent were applied to determine the survival rates of 1000000 and 10000000 CFU/mL of S. aureus after being incubated with 10% (v/v) mouthwash. These results could indicate the anti-bacterial ability of mouthwash to S. aureus.
Measured: One week after the intervention
Secondary outcomes (1)
The percentage change in the TOBC after the intervention
The percentage change ((TOBC after intervention - TOBC before intervention)/ TOBC before intervention)*100%) in the TOBC of the MW, MWF, and control groups was determined after the intervention. Further to normalize the TOBC data by base-2 log-transformation, the change of TOBC were also determined after the intervention. Finally, the linear regression analysis was applied to determine the risk factors which could significantly affect the percentage change in TOBC after the intervention.
Measured: One month after the intervention
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted13 May 2022
- Study start20 Mar 2020
- Primary completion7 Feb 2022
- Study completion22 Feb 2022
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Periodontal DiseasesStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Basic science
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- The volunteers of patients with and without periodontal disease were recruited in the same day. Patients with periodontal disease were randomized into mouthwash group and mouthwash plus periodontal flosser group. Patients without periodontal disease were recruited as the control group.
- Masking
- Double blind
- Who is masked
- Participant, Outcomes assessor
- Enrolment
- 83 participants (actual)
Sponsor and investigators
- Lead sponsor
- Kaohsiung Medical University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Ying-Chu Lin, Kaohsiung Medical University
- Investigators
- Hsian-Ling Huang, Ph.D., Principal investigator, Kaohsiung Medical UniversityYing-Chu Lin, Ph.D., Principal investigator, Kaohsiung Medical University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05372835
- Sponsor's protocol ID
- KMUHIRB-F(I)-20200042
- Status last verified
- May 2022
- First submitted
- 28 Apr 2022
- Last updated
- 13 May 2022
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Lin YC, Tsai CF, Huang HL. Effects of hypochlorous acid mouthwash on salivary bacteria including Staphylococcus aureus in patients with periodontal disease: a randomized controlled trial. BMC Oral Health. 2023 Sep 28;23(1):698. doi: 10.1186/s12903-023-03358-4.
PubMed 37770865
Study at a glance
From the registry record, last updated by the sponsor on 13 May 2022. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Effects of Hypochlorous Acid Mouthwash on Oral Bacteria in Patients With Periodontal Disease and Staphylococcus Aureus
- ClinicalTrials.gov ID
- NCT05372835
- Acronym / sponsor ID
- KMUHIRB-F(I)-20200042
- Conditions
- Periodontal Diseases
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 83 participants (actual)
- Lead sponsor
- Kaohsiung Medical UniversityUniversity, hospital or other
- Study start
- 20 Mar 2020 (actual)
- Primary completion
- 7 Feb 2022 (actual)
- Study completion
- 22 Feb 2022 (actual)
- First posted
- 13 May 2022 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Mouthwash is one method of maintain oral health and to reduce the dental plaque and gum inflammation. However, the effects of mouthwash on oral bacteria were not consistent among different brands of them. The aims of present study were to determine the effects of a new designed mouthwash with hypochlorous acid on oral bacteria and Staphylococcus aureus. All participants were invited as a volunteer to attend this study from a private dental clinic and diagnosed by the same dentist. Patients with periodontal diseases were randomized selected as mouthwash group and mouthwash plus dental flossing device (La Chlogen, Taiwan) group. Patients for regular dental visit and without periodontal disease were invited as a control group having mouth rinse with water. After the inform consent was signed, participants completed the intervention study, saliva collection, and a simple survey under the guide of a dental assistant. Saliva samples were collected before and after the intervention for bacterial DNA extraction. A real-time polymerase chain reaction and S. aureus with serial dilutions were applied for the estimation of total oral bacterial count (TOBC) in saliva. An in vitro assay with CCK-8 reagent was apply to test the antibacterial ability of mouthwash.
Detailed description
Finally there were 83 person recruited into the present study. A total of 53 patients with periodontal disease diagnosed by a periodontist, who were randomly assigned to the mouthwash-only group (26 patients) or the mouthwash plus periodontal flosser group (27 patients). There were 30 controls recruited into the present study. For the determination of oral bacterial counts, a real-time polymerase chain reaction and a pure strain of Staphylococcus aureus with a serial dilutions were applied to create a standardized growth curve for the estimation of oral bacterial counts in saliva. Before the intervention, participants were asked to rinse 5 ml of water to deplete the food debris and the other residues in mouth. The intervention was asked participants to rinse the 15 ml mouthwash or water for 5 minutes in oral cavity.
Participants were asked their health history and use of dental cleaning tools. The participants underwent relevant oral health examinations, and their oral health indices were also recorded. The mouthwash used for intervention in the present study was the 15 mL of commercially available La Chlogen mouthwash (Republic of China Patent No. M616466) for 5 minites. The main ingredient in the mouthwash is low-concentration high-purity HOCl (100 ppm). The HOCl solutions can be also used in conjunction with the La Chlogen periodontal flosser (Republic of China Patent No. M590033). The controls were instructed to gargle with pure water (15 ml) for 5 minutes. Each participant first underwent a pretest, in which after the participants' saliva samples were collected, their total oral bacterial count (TOBC) were measured. Thereafter, each participant rinsed their mouth with their assigned liquid (mouthwash, mouthwash plus periodontal flosser or water) without spitting. After 5 minutes, the participants spit out the liquid, and these saliva samples were collected and tested to determine the TOBC.
Each participant underwent two saliva sample collection sessions: pretest and posttest. Before the saliva collection, participant rinsed with 5 ml of water. After this, participants were asked to expectorate over a maximum period of 3 minutes into a 50 ml sterile centrifugation tube (Creative Biotechnology Co., Ltd., Taiwan) for the collection of unstimulated whole saliva. The collected specimen was then immediately placed in a portable ice box for storage, returned to the laboratory for the same-day bacterial DNA extraction. The saliva volume and weight of each sample was also recorded before the bacterial genomic DNA extraction process.
TOBC analysis: After the extraction of the bacterial genomic DNA, The real-time polymerase chain reaction (RT-PCR) techniques were used to quantify the total counts of oral bacteria in the saliva samples. Saliva sample was centrifuged at 2500 rpm for 5 minutes. The pellet was suspended with 300µl lysozyme solution (2.5 mg/mL). After being mixed evenly, the mixture was transferred into a 1.5mL eppendorf tube and placed on ice for 1 hour. Thereafter, 10% SDS (20µL), 0.5M EDTA (80µL), and 20mg/mL proteinase K (10µL) were added to each tube in sequence; the contents of each tube were mixed evenly and placed in a 55°C oven for overnight. Next, 10M NH4OAC was added to the mixture in equal volume. The mixture was placed on ice for 5 minutes and centrifuged at 13,000 rpm for 10 minutes. The resulting supernatant was placed into a 1.5-mL centrifuge tube. Isopropanol was added to the resulting mixture in equal volume, and the mixture was stored at -20°C for overnight or -80°C for 1 hour. After centrifugation for 10 minutes at 13,000 rpm, the supernatants were removed from the precipitates, 75% alcohol (500µL) was added and left to stand for 5 minutes, and the mixture was centrifuged for 10 minutes at 13,000 rpm. The alcohol was then removed. Next, 100% alcohol (500µL) was added to the pellet. The mixture was left to stand for 5 minutes and subsequently centrifuged for 10 minutes at 13,000 rpm. Finally, the alcohol in the tube was poured out, and the centrifuge tube was placed upside down to allow any remaining alcohol to evaporate. Finally, the DNA precipitates were dissolved using an appropriate amount of sterilized water, placed into an oven at 55°C for 5 minutes, and stored at -20°C. Generally, the DNA specimens with an OD260/ OD280 ratio of 1.4 or higher. The concentration of recovered DNA was calculated on the basis of a concentration of 50 µg/mL at OD260 = 1.00, which was determined to be suitable for estimating the TOBC of each sample after the DNA quantification. Staphylococcus aureus (ATCC 29213) was used as the reference strain in bacterial growth curve estimation. After overnight culturing, the bacterial solution was serially diluted five times to generate specimens with different concentrations of S. aureus. A total of 10 µL of each of the specimens were taken and spread on the agar medium to attain concentrations of 2.5 × 103 to 3.9 × 107 CFU/mL. A volume of 1 mL of each different bacterial concentration was taken for bacterial DNA extraction. The extracted bacterial genomic DNA was stored frozen at -80°C until the RT-PCR test was conducted. Before the RT-PCR test, the bacterial genomic DNA concentration was measured. RT-PCR tests mainly detect 16S rRNA, and a StepOnePlus system (Applied Biosystems, Foster City, CA, USA) was used to establish a standard curve of S. aureus concentration. The sequence of the forward primer and reverse primer used were 5'-CCT ACG GGA GGC AGC AG-3' and 5'-CCG TCA ATT CMT TTR AGTT T-3', respectively.16 The coverage rates of selected forward and reverse primer pair for common bacterial species are 94.9% and 92.8%, respectively.16 The total PCR volume was 25 uL, comprising 5.5 µL of ddH2O, 1.0 µL of 5-µM preprimer, 1.0 µL of 5-µM reverse primer, 12.5 µL of SYBR solution, and 5.0 µL (0.25 µg) of DNA. The RT-PCR reaction conditions were as follows: 94°C for 10 minutes; followed by 35 cycles of 95°C for 45 seconds, 58°C for 40 seconds, and 72°C for 60 seconds; and followed by one cycle of 72°C for 7 minutes. A regression equation derived from the standard curve and the RT-PCR results were used to calculate the bacterial concentration in each saliva sample. The RT-PCR assay was conducted two duplicates for each sample, and the coefficient of variation of the threshold was varied between 2% and 12%. Human blood DNA was used as a negative control group.
Antibacterial activity of the mouthwash solution: The pure-cultured S. aureus used as the standard strain was plated on a culture plate (10 cm in diameter) containing 1.5% (g/L) luria broth agar and cultured overnight. A single colony was selected and placed in a conical flask containing LB nutrient liquid, shaken, and recultured overnight, and the resulting solution was serially diluted and coated on the plate to calculate the number of bacteria per unit volume. Finally, a Cell Counting Kit 8 (CCK-8, Engreen Biosystem) commercial reagent was used to evaluate the antibacterial effect of the mouthwash. Each experiment was performed in duplicate. Solutions containing different colony forming units (0, 10, 100, 1000, 10000, 100000, and 1000000) of S. aureus were centrifuged at 2000 rpm for 5 minutes to concentrate the bacteria; after the liquid was removed, 180 µL of fresh culture medium was added to suspend the bacteria in the culture medium. The bacteria solution was transferred to a 96-well plate. To evaluate the antibacterial effect of the mouthwash, 20 µL of the mouthwash was added to the mixture of the bacterial solution. The mixture was incubated at 37°C for 2 hours. Finally, 10 µL of CCK-8 reagent was added and mixed well. The resulting mixture was incubated at 37°C for 2 hours, and the absorbance at 450 nm was measured using an ELISA reader. The standard growth curve could be established for the estimation of the number of bacteria in the mixture and their survival rate of the bacteria, which were then compared with the standard curve.
Statistical analysis: After the data collection and checking were complete, the finalized debugged files were transferred to a computer with statistical software for statistical analysis. The descriptive statistics used included frequency distribution tables, percentages, means, and standard deviations. In the TOBC analysis, in addition to descriptive statistics, a t test, chi-square test, and linear regression analysis were conducted to assess and compare the changes in the bacterial counts of the participants' saliva after the intervention period. Considering the small sample size and the distribution of TOBC, nonparametric statistical methods were used for analysis. The Wilcoxon rank-sum test was used to identify differences in the numerical data of the intervention group and the control group, the Wilcoxon signed-rank test was used to identify changes in numerical data between the baseline and post-intervention, and the Kruskal-Wallis test and a post hoc Tukey test were used to identify differences in numerical data of three or more groups.
Study design
- Primary purpose
- Basic science
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind (participant, outcomes assessor)
- Number of arms
- 3
- Model description
- The volunteers of patients with and without periodontal disease were recruited in the same day. Patients with periodontal disease were randomized into mouthwash group and mouthwash plus periodontal flosser group. Patients without periodontal disease were recruited as the control group.
| Arm | Type | Receives |
|---|---|---|
| mouthwash | Experimental | Other: La Chlogen mouthwashThe 15 mL of commercially available La Chlogen mouthwash (Republic of China Patent No. M616466) was used for intervention to rinse in mouth for 5 minutes. The main ingredient in the mouthwash is low-concentration high-purity HOCl (100 ppm) solution. |
| mouthwash and periodontal flosser | Experimental | Other: La Chlogen mouthwash and La Chlogen periodontal flosserThe 15 ml of commercially available La Chlogen mouthwash (Republic of China Patent No. M616466) in conjunction with the La Chlogen periodontal flosser (Republic of China Patent No. M590033) were used for intervention in the mouth for 5 minutes. The main ingredient in the mouthwash is low-concentration high-purity HOCl (100 ppm) solution. |
| control | Placebo comparator | Other: waterThe pure water without HOCl chemical was applied in this intervention to rinse in mouth for 5 minutes. |
Who may qualify
- Ages
- 35 to 70 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (3 listed)
- All the participants were between 35 and 70 years old.
- Clinical diagnosis of periodontal disease
- Must be able to rinse liquid (mouthwash or water) in mouth and split out saliva into a collection tube
Key exclusion criteria (7 listed)
- diagnosed mental illness
- incapacitated patients
- antibiotics or immunosuppressive drugs taken for the two consecutive weeks preceding study commencement
- pregnant
- smokers
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| La Chlogen mouthwashPatients with periodontal disease were randomized into mouthwash group. Before the intervention, participants were asked to rinse 5 ml of water to deplete the food debris and the other residues. After this, the intervention was asked participants to rinse the commercially available La Chlogen mouthwash in mouth without spitting. After 5 minutes, the participants spit out the liquid, and the saliva samples were collected for further analysis. | Other | mouthwash |
| waterPatients without periodontal disease were selected as a control group. Before the intervention, participants were asked to rinse 5 ml of water to deplete the food debris and the other residues. After this, the intervention was asked participants to rinse the pure water in mouth without spitting. After 5 minutes, the participants spit out the liquid, and the saliva samples were collected for further analysis. | Other | control |
| La Chlogen mouthwash and La Chlogen periodontal flosserPatients with periodontal disease were randomized into mouthwash and periodontal flosser group. Before the intervention, participants were asked to rinse 5 ml of water to deplete the food debris and the other residues. After this, the La Chlogen mouthwash in conjunction with the La Chlogen periodontal flosser were applied in mouth without spitting for interventions. After 5 minutes, the participants spit out the liquid, and the saliva samples were collected for further analysis. | Other | mouthwash and periodontal flosser |
Primary outcome
Total oral bacterial count before the intervention
Time frame: Before the intervention starting
Before the intervention, saliva samples were collected for oral bacterial DNA extraction.The saliva volume and weight of each sample was also recorded before the bacterial genomic DNA extraction process. A real-time polymerase chain reaction and S. aureus with serial dilutions were applied for the estimation of total oral bacterial count (TOBC) in saliva. The differences in TOBC among the mouthwash group (MW), mouthwash and periodontal flosser group (MWF), and control group were determined using statistical analysis.
Total oral bacterial count after the intervention
Time frame: Immediately after the intervention
After the intervention, saliva samples were collected for oral bacterial DNA extraction. The saliva volume and weight of each sample was also recorded before the bacterial genomic DNA extraction process. A real-time polymerase chain reaction and S. aureus with serial dilutions were applied for the estimation of total oral bacterial count (TOBC) in saliva. The difference in TOBC between before and after intervention was determined using statistical analysis
Survival rate of S. aureus after the incubation with 10% (v/v) mouthwash
Time frame: One week after the intervention
An in vitro assay and CCK-8 reagent were applied to determine the survival rates of 1000000 and 10000000 CFU/mL of S. aureus after being incubated with 10% (v/v) mouthwash. These results could indicate the anti-bacterial ability of mouthwash to S. aureus.
1 secondary outcome
The percentage change in the TOBC after the intervention
Time frame: One month after the intervention
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 13 May 2022.
- Derived from this study: PubMed 37770865Lin YC, Tsai CF, Huang HL. Effects of hypochlorous acid mouthwash on salivary bacteria including Staphylococcus aureus in patients with periodontal disease: a randomized controlled trial. BMC Oral Health. 2023 Sep 28;23(1):698. doi: 10.1186/s12903-023-03358-4.
- Individual participant dataSharing planned: No
Related trials for Periodontal Diseases
Not yet recruitingObservational study
Periodontal Status and Biomarkers in MASLD
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Recruiting
Thermosensitive Hyaluronic Gel With Octenidine as an Adjunctive to Subgingival Instrumentation
Periodontal Disease
Active, not recruitingObservational study
A Retrospective Comparative Evaluation of Omega-3 and Resveratrol Supplementation in Patients With Periodontitis
Periodontitis
Recruiting
Effects of Different Activation Techniques on Antimicrobial Photodynamic Therapy in Apical Periodontitis
Apical Periodontitis, Endodontic Retreatment
Recruiting
Ozone Gel Versus Chlorohexidine Gel as an Adjunct to Non-Surgical Treatment of Stage II Periodontitis Grade B Among Smokers Patients
Ozone Gel, Chlorohexidine Gel
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Hsian-Ling Huang, Ph.D. principal investigator
Kaohsiung Medical University
Ying-Chu Lin, Ph.D. principal investigator
Kaohsiung Medical University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing La Chlogen mouthwash, water and La Chlogen mouthwash and La Chlogen periodontal flosser in people with Periodontal Diseases, run by Kaohsiung Medical University at 1 site in Taiwan.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 13 May 2022. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Taiwan. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Total oral bacterial count before the intervention (time frame: Before the intervention starting). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT05372835, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 May 2022.